Skip to main content

Advertisement

Table 3 Characteristics of HPV + participants by whether or not they successfully presented for treatment

From: Evaluating a community-based cervical cancer screening strategy in Western Kenya: a descriptive study

Variable Total N Unable to present for treatment (no-show) % Presented for treatment % Unadjusted Odds Ratio of Presenting for Treatment (95% CI)
Total (N, %) N = 46 N = 23 (49%) N = 24 (51%)  
Age (mean, SD) 34 (12) 31 (11) 36 (12) 1.04 (0.99–1.10)
Age: categorical
 25–29 yo 24 58 42 0.29 (0.05–1.78)
 30–39 yo 12 50 50 0. 40 (0.05–2.93)
 40–49 yo 4 25 75 1.20 (0.07–19.63)
  > = 50 yo 7 29 71 1.0
Prior Screening HIstory
 None prior 38 50 50 1.0
 Prior screening 9 44 56 1.25 (0.29–5.39)
HIV serostatus
 HIV- 34 47 53 1.0
 HIV+ 12 50 50 0.89 (0.24–3.32)
Family Planning
 No method 29 48 52 1.0
 Using a method 18 50 50 0.93 (0.29–3.03)
Pregnant
 Not pregnant 42 48 52 1.0
 Currently pregnant 3 100 0 too few observations
Have access to a mobile phone
 No access 8 63 37 1.0
 Has phone 39 46 54 1.94 (0.41–9.29)
Notification of test results via:
 Text 17 53 47 1.0
 Phone call 11 55 45 0.94 (0.20–4.29)
 Home visit 12 25 75 3.38 (0.67–17.00)
 Clinic visit 7 71 29 0.45 (0.34–2.30)